Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SRLS

SeraCare Life Sciences (SRLS) Stock Price, News & Analysis

About SeraCare Life Sciences Stock (NASDAQ:SRLS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.

Receive SRLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeraCare Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SRLS Stock News Headlines

KS1 Science: Animal life cycles
KS1 Science: Plant life cycles
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Suven Life Sciences Ltd (SUVP)
Pharma gap threat to life sciences plan
Amag: Hedge Fund Makes Takeover Bid
See More Headlines

SRLS Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that SeraCare Life Sciences investors own include Proto Labs (PRLB) and Canopy Growth (CGC).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:SRLS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:SRLS) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners